Less Ads, More Data, More Tools Register for FREE

Pin to quick picksSavills Regulatory News (SVS)

Share Price Information for Savills (SVS)

Share Price is delayed by 15 minutes
Get Live Data
824.00    2.00 (0.24%)
Bid:
824.00
Ask:
825.00
Spread: 1.00 (0.121%)
Market Cap: £1.14b
SVS Live PriceLast checked at - London Stock Exchange

Intraday Savills Share Chart

AGM Statement and Interim Management Statement

4 May 2011 11:30

RNS Number : 8938F
Savills PLC
04 May 2011
 



4 May 2011

SAVILLS PLC

("Savills" or "the Company")

 

AGM Statement and Interim Management Statement

 

Savills plc, the international real estate advisor, is today holding its Annual General Meeting (AGM) at 12 noon, 20 Grosvenor Hill, Berkeley Square, London W1K 3HQ and provides the following Interim Management Statement (IMS) for the period to 4 May 2011.

 

During the first four months of the year Savills has traded in line with the expectations that we highlighted at our full year results in March. The first quarter saw the anticipated continuation of strong markets in Asia, improved trading in the US and, by quarter end, a strong performance from the UK Residential business, principally in central London. The UK Commercial and Cordea Savills' fund management businesses, are also performing as anticipated. In Continental Europe, the core markets of France, Germany and Sweden have shown aggregate revenue growth over the comparative period last year, although trading in other markets continues to be affected by weak economic conditions.

 

As announced yesterday, Savills has sold a majority stake (80.01%) in Savills Private Finance Limited to the management team.

 

London's attractions as an investment location are well known. However, the current political and economic turbulence in many parts of the world has undoubtedly resulted in further significant interest in the capital's prime residential property during this period. Savills has enjoyed the leading market share in London properties valued at more than £5 million. In addition, the increase in UK Stamp Duty created a short term surge in completions in March, although we anticipate from previous experience, that the impact of such changes is generally short term in nature. In Hong Kong and Singapore we have experienced a strong first quarter and, as anticipated, we are seeing signs of potential slowing in market activity which could affect the second half of the year.

 

Our US business continues to build momentum and we have hired a team of investment professionals focused on cross border business. Supporting this activity, in April we formed Savills Liberty Street Asset Management LLC, a joint venture with Silverpeak Real Estate Partners to provide a strategic asset management service to clients with portfolios and individual property holdings in the US. Furthermore we have announced today that we have entered into a strategic alliance with CresaPartners LLC, a 55 office firm in North America focused on tenant representation. This will enable both firms to offer tenant representation services through a combined global network of over 250 offices.

 

Overall, we are pleased with the performance of the Group with an improved outlook for London residential compensating for a potential shortfall in some Continental European markets and with the rest of the Group performing as expected at this stage in the year.

 

For further information, contact:

 

Savills 020 7409 8844

Jeremy Helsby, Group Chief Executive

Simon Shaw, Group Chief Financial Officer

 

Tulchan Communications 020 7353 4200

John Sunnucks

Peter Hewer

 

 

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
IMSGMGGKLDFGMZG
Date   Source Headline
1st Jun 202611:29 amRNSTotal Voting Rights
22nd May 202610:09 amRNSDirector/PDMR Shareholding
14th May 202612:41 pmRNSResult of AGM
13th May 20264:16 pmRNSResult of AGM
13th May 20267:00 amRNSAGM Statement
12th May 20263:41 pmRNSDirector/PDMR Shareholding
7th May 20263:39 pmRNSDirector Declaration
29th Apr 20263:04 pmRNSReplacement - Director/PDMR Shareholding
29th Apr 20261:23 pmRNSDirector/PDMR Shareholding
28th Apr 20261:58 pmRNSDirector/PDMR Shareholding
13th Apr 20265:24 pmRNSHolding(s) in Company
13th Apr 20262:10 pmRNSDirector/PDMR Shareholding
7th Apr 20264:03 pmRNSAnnual Report and AGM Notice
1st Apr 202610:00 amRNSTotal Voting Rights
31st Mar 202612:55 pmRNSDirector/PDMR Shareholding
26th Mar 20268:57 amRNSDirector/PDMR Shareholding
24th Mar 202611:02 amRNSDirector/PDMR Shareholding
23rd Mar 20269:27 amRNSDirector/PDMR Shareholding
18th Mar 20263:47 pmRNSDirector/PDMR Shareholding
16th Mar 20262:33 pmRNSHolding(s) in Company
16th Mar 20262:33 pmRNSHolding(s) in Company
16th Mar 20262:00 pmRNSHolding(s) in Company
16th Mar 20262:00 pmRNSHolding(s) in Company
16th Mar 202611:51 amRNSDirector/PDMR Shareholding
16th Mar 202611:51 amRNSDirector/PDMR Shareholding
16th Mar 202611:49 amRNSDirector/PDMR Shareholding
16th Mar 202611:49 amRNSDirector/PDMR Shareholding
13th Mar 20261:34 pmRNSDirector/PDMR Shareholding
13th Mar 20261:32 pmRNSDirector/PDMR Shareholding
12th Mar 20267:26 amRNSSignificant Transaction
12th Mar 20267:26 amRNSSignificant Transaction
12th Mar 20267:08 amRNSFinal Results
11th Mar 20264:21 pmRNSDirector/PDMR Shareholding
11th Mar 20264:21 pmRNSDirector/PDMR Shareholding
5th Mar 20265:00 pmRNSHolding(s) in Company
2nd Mar 20269:11 amRNSTotal Voting Rights
25th Feb 202611:14 amRNSHolding(s) in Company
11th Feb 20264:07 pmRNSDirector/PDMR Shareholding
4th Feb 20265:29 pmRNSHolding(s) in Company
2nd Feb 20265:32 pmRNSTotal Voting Rights
19th Jan 20268:30 amRNSDirectorship change
15th Jan 20267:00 amRNSYear End Trading Update
13th Jan 20265:40 pmRNSDirector/PDMR Shareholding
13th Jan 202612:59 pmRNSHolding(s) in Company
2nd Jan 20263:00 pmRNSTotal Voting Rights
11th Dec 20252:00 pmRNSDirector/PDMR Shareholding
1st Dec 20259:49 amRNSTotal Voting Rights
11th Nov 20254:58 pmRNSDirector/PDMR Shareholding
3rd Nov 202512:32 pmRNSTotal Voting Rights
13th Oct 20251:33 pmRNSDirector/PDMR Shareholding

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.